Artificial intelligence (AI) is changing evidence synthesis. It offers clear opportunities to accelerate and streamline the way systematic literature reviews (SLRs) are conducted. However, efficiency alone is not enough, evidence…

At Broadstreet we do a lot of work with real world evidence (RWE), frequently using administrative health data sources. Being able to standardize how cohorts for these types of studies…

HTA submissions rely heavily on comparisons of treatments, and numerous methodologies have been developed to estimate relative treatment effects across studies in a rigorous fashion. The traditional methods (such as…

Broadstreet is pleased to have contributed to seven studies being presented at ISPOR on subjects ranging from patient preferences for chronic obstructive pulmonary disease (COPD) maintenance treatment delivery devices to…

Phenylketonuria (PKU) is a rare genetic disorder that causes harmful levels of the dietary protein phenylalanine (Phe), an essential amino acid and a fundamental building block of protein, to build…

Qualitative research can is valuable for its potential to provide in depth insights into complex issues and is particularly valuable for capturing patient perspectives. It can be used to inform…

Broadstreet will be featuring seven of our research projects at ISPOR Europe 2025. Subjects range from health-related quality-of-life in hypophosphatasia to physician perspectives on unmet need and treatment options in…

Broadstreet takes of a broad variety of work in the health economics and outcomes space. We thought we would share a few of our recent publications which reflect that diversity.…

ISPOR is coming to Canada this year, taking place in Montreal, May 5th to 8th. Broadstreet is pleased to be involved in six studies being presented on subjects ranging from…